Herbalife Ltd. (NYSE: HLF) has reaffirmed its third-quarter and full-year 2026 financial guidance, originally issued on Aug. 5, 2026, according to a company statement.

The company continues to project year-over-year net sales growth for both periods on a reported and constant currency basis. For the third quarter, reported net sales growth is expected in a range of +0.5% to +4.5% year-over-year, with adjusted EBITDA of $160 million to $180 million. On a constant currency basis, third-quarter net sales growth is projected at +1.5% to +5.5%, with adjusted EBITDA of $165 million to $185 million.

For the full year, reported net sales growth is expected at +2.5% to +5.5% year-over-year, with adjusted EBITDA of $670 million to $690 million. On a constant currency basis, full-year net sales growth is also projected at +2.5% to +5.5%, with adjusted EBITDA of $690 million to $710 million.

Capital expenditures for the third quarter are guided at $15 million to $25 million, and $50 million to $70 million for the full year. The company also reaffirmed capitalized SaaS implementation costs of $35 million to $55 million, depreciation and amortization of $140 million to $150 million, and an adjusted effective tax rate of approximately 35% for the full year.

"Our outlook for the remainder of the year remains firmly on track," said John DeSimone, Chief Financial Officer. "We remain confident in our ability to deliver a fifth consecutive quarter of year-over-year net sales growth and continued momentum across the remainder of 2026."

The company stated that its guidance assumptions, including foreign exchange rates, are unchanged from those disclosed on Aug. 5, 2026.